Medicare could be saving a lot of cash by switching to generic constituents for some drugs—maybe as much as a billion dollars.
A recent study estimated spending in 2016 on 29 brand-name combination products would have been $925 million more than spending for generic counterparts.

Screening mammography is a reasonable surveillance tool for breast cancer patients treated with mastectomy and breast reconstruction with autologous myocutaneous flaps (AMFs), according to new research published in Radiology. Mammography provides little additional value, however, if the patient had reconstruction after a prophylactic mastectomy.

Nearly 20 percent of U.S. hospitals are at risk of potential closure or are in weak shape, according to a recent report from Morgan Stanley.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors, an independent nonprofit organization authorized by Congress, has approved $85 million for 16 new studies to improve care and outcomes for several conditions.

A locum radiologist working at Mayo University Hospital in Castlebar, Ireland, reportedly failed to read an elderly woman’s CT correctly upon her admission in September 2017, missing a rectal tumor that killed her two weeks later, the Mayo News reported this week.

The publicly available prices of 30 frequently prescribed cardiovascular drugs don’t necessarily correlate to clinical value, according to a new study. Some drugs were both cheaper and more effective than alternatives, while others were more expensive and associated with poorer outcomes.

Amyloid PET could be a useful diagnostic tool for patients with mild cognitive impairment (MCI) or suspected Alzheimer’s, according to a study published this summer in JAMA Neurology, yielding changes in diagnosis, treatment decisions and physician confidence regardless if scan results are positive or negative.

Online retail giant Amazon has made another splash into the healthcare pond by hiring cardiologist Maulik Majmudar, MD.